Cyclerion Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
4.00
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
1
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.30
|
0.00
|
0.30
|
100.00%
|
|
2022-12-31
|
-0.29
|
0.00
|
0.29
|
100.00%
|
|
2022-09-30
|
-0.31
|
-0.24
|
0.07
|
22.58%
|
|
2022-06-30
|
-0.30
|
-0.31
|
-0.01
|
-3.33%
|
|
2022-03-31
|
-0.36
|
-0.30
|
0.06
|
16.67%
|
|
2021-12-31
|
-0.30
|
-0.33
|
-0.03
|
-10.00%
|
|
2021-09-30
|
-0.35
|
-0.26
|
0.09
|
25.71%
|
|
2021-06-30
|
0.00
|
-0.45
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.85
|
|
2021-12-31
|
-1.43
|
|
2020-12-31
|
-2.56
|
|
2019-12-31
|
-4.05
|
|
2018-12-31
|
-5.32
|